Das Neueste aus der Oxalacetat-Forschung

IACFS/ME Lecture On Therapeutic Use of Oxaloacetate in ME/CFS and Long COVID by Dr. Vernon of Bateman Horne Center

IACFS/ME Lecture On Therapeutic Use of Oxaloace...

Dr. Susan Vernon Discusses Clinical Data of Oxaloacetate Showing Fatigue and Cognitive Function Improvements in ME/CFS and Long COVID patients At the forefront of ME/CFS research, the Bateman Horne Center...

IACFS/ME Lecture On Therapeutic Use of Oxaloace...

Dr. Susan Vernon Discusses Clinical Data of Oxaloacetate Showing Fatigue and Cognitive Function Improvements in ME/CFS and Long COVID patients At the forefront of ME/CFS research, the Bateman Horne Center...

Bateman Horne Center Deepens the Science Behind Oxaloacetate for ME/CFS and Long COVID

Bateman Horne Center Deepens the Science Behind...

The journey toward effective treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID has long been hindered by a lack of objective measurement and translational research grounded in the...

Bateman Horne Center Deepens the Science Behind...

The journey toward effective treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID has long been hindered by a lack of objective measurement and translational research grounded in the...

Oxaloacetate improves Cognition in ME/CFS and Long COVID

Oxaloacetate improves Cognition in ME/CFS and L...

In a newly published article in “Frontiers in Neurology”, a double-blinded, randomized, controlled clinical trial at the Bateman Horne Center, an ME/CFS Center of Excellence, found that a metabolite, “Oxaloacetate,”...

Oxaloacetate improves Cognition in ME/CFS and L...

In a newly published article in “Frontiers in Neurology”, a double-blinded, randomized, controlled clinical trial at the Bateman Horne Center, an ME/CFS Center of Excellence, found that a metabolite, “Oxaloacetate,”...

New Double-Blind Clinical Trial: Oxaloacetate Improves Both Cognitive Performance and Physical Function in ME/CFS

New Double-Blind Clinical Trial: Oxaloacetate I...

A new randomized, double-blind clinical trial peer-reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), while also...

New Double-Blind Clinical Trial: Oxaloacetate I...

A new randomized, double-blind clinical trial peer-reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), while also...

New Research Suggests Oxaloacetate Supplementation as an Antiviral Defense

New Research Suggests Oxaloacetate Supplementat...

Just published in the journal “Nature Microbiology” the article, “Oxaloacetate sensing promotes innate immune antiviral defence against influenza virus infection.”  The article uncovers a new function of oxaloacetate supplementation—to promote...

New Research Suggests Oxaloacetate Supplementat...

Just published in the journal “Nature Microbiology” the article, “Oxaloacetate sensing promotes innate immune antiviral defence against influenza virus infection.”  The article uncovers a new function of oxaloacetate supplementation—to promote...

AI Accelerates ME/CFS Research: A Milestone Week for the Field

AI Accelerates ME/CFS Research: A Milestone Wee...

It’s a sign that the scientific community is not only paying attention but is committed to accelerating progress for people living with ME/CFS. Integrating Multi-Omics Data for InsightFrom multi-omics modeling...

AI Accelerates ME/CFS Research: A Milestone Wee...

It’s a sign that the scientific community is not only paying attention but is committed to accelerating progress for people living with ME/CFS. Integrating Multi-Omics Data for InsightFrom multi-omics modeling...